A Study of NTX-1088 as Monotherapy and Combined with Pembrolizumab

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-520077-12-00

Acronym

NTX-1088-01

Enrollment

Registered

2025-07-07

Start date

2025-09-15

Completion date

Unknown

Last updated

2025-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with Advanced Solid Malignancies

None listed

Sex/Gender

All

Age

18 Years to No maximum

Poland

None listed

Source: EU CTIS · Data processed: Feb 4, 2026